DNA methylation-based classification of human central nervous system tumors
Martin Sill
2018
2018/1/18
United States, Cabin John
DKFZ
数据描述
This SuperSeries is composed of the SubSeries listed below.
关键词
1Homo sapiens
www.ncbi.nlm.nih.gov
IP: 130.14.29.110
加载中...
相关论文
9Prediction of brain metastasis development with DNA methylation signatures
Jeffrey A. Zuccato•Yasin Mamatjan•Farshad Nassiri•Andrew Ajisebutu•Jeffrey C. Liu等 21 人
Nature Medicine
2024
•2024/10/8
•00 p.1-10
Brain metastases (BMs) are the most common and among the deadliest brain tumors. Currently, there are no reliable predictors of BM development from primary cancer, which limits early intervention. Lung adenocarcinoma (LUAD) is the most common BM source and here we obtained 402 tumor and plasma sampl...
CNS cancerDiagnostic markersMethylation analysisNon-small-cell lung cancerPredictive markers
10.1038/S41591-024-03286-Y
ISSN:1078-8956
Multi-omics integration unravels four molecular subgroups of corticotroph pituitary neuroendocrine tumours with distinct clinicopathological features
Matthias Dottermusch•Alice Ryba•Antonia Gocke•Temor Rafiq•Celina Soltwedel等 21 人
Nature Communications
2026
•2026/8/4
•Vol.17 No.1 p.77770
Corticotroph pituitary neuroendocrine tumours (PitNETs)/adenomas are heterogeneous sellar neoplasms. Currently established histopathological classification approaches are often considered limited in fully capturing the clinical and biological complexity of these tumours. Thus far, a molecular-based ...
Classification and taxonomyDNA methylationPituitary diseasesPituitary tumoursProteomics
10.1038/S41467-026-76292-Y
ISSN:2041-1723
Ultra-fast deep-learned CNS tumour classification during surgery
C. Vermeulen•M. Pagès-Gallego•L. Kester•M. E. G. Kranendonk•P. Wesseling等 14 人
Nature
2023
•2023/10/11
•00 p.1-8
Central nervous system tumours represent one of the most lethal cancer types, particularly among children1. Primary treatment includes neurosurgical resection of the tumour, in which a delicate balance must be struck between maximizing the extent of resection and minimizing risk of neurological dama...
BioinformaticsCNS cancerDiagnostic markersNext-generation sequencing
10.1038/S41586-023-06615-2
ISSN:0028-0836
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
Grayson A. Herrgott•James M. Snyder•Ruicong She•Tathiane M. Malta•Thais S. Sabedot等 35 人
Nature Communications
2023
•2023/9/13
•Vol.14 No.1 p.1-19
Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation lev...
CNS cancerDiagnostic markersPredictive markersPrognostic markers
10.1038/S41467-023-41434-Z
ISSN:2041-1723
A prognostic neural epigenetic signature in high-grade glioma
Richard Drexler•Robin Khatri•Thomas Sauvigny•Malte Mohme•Cecile L. Maire等 46 人
Nature Medicine
2024
•2024/5/17
•00 p.1-14
Neural–tumor interactions drive glioma growth as evidenced in preclinical models, but clinical validation is limited. We present an epigenetically defined neural signature of glioblastoma that independently predicts patients’ survival. We use reference signatures of neural cells to deconvolve tumor ...
CNS cancerDNA methylationTranslational research
10.1038/S41591-024-02969-W
ISSN:1078-8956
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Petr Smirnov•Moritz J. Przybilla•Milena Simovic-Lorenz•R. Gonzalo Parra•Hana Susak等 26 人
Nature Communications
2024
•2024/11/23
•Vol.15 No.1 p.1-20
Chromothripsis is a frequent form of genome instability, whereby a presumably single catastrophic event generates extensive genomic rearrangements of one or multiple chromosome(s). However, little is known about the heterogeneity of chromothripsis across different clones from the same tumour, as wel...
Cancer genomicsCNS cancerTumour heterogeneity
10.1038/S41467-024-54547-W
ISSN:2041-1723
Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models
Melanie Schoof•Tuyu Zheng•Martin Sill•Roland Imle•Alessia Cais等 54 人
Nature Genetics
2025
•2025/12/11
•00 p.1-14
Copy number alterations (CNAs) are hallmarks of cancer, yet investigation of their oncogenic role has been hindered by technical limitations and missing model systems. Here we generated a genome-wide DNA methylation and CNA atlas of 106 genetic mouse models across 31 pediatric tumor types, including...
CancerEpigeneticsExperimental models of diseaseGenetics research
10.1038/S41588-025-02419-4
ISSN:1061-4036
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Salvatore Benfatto•Martin Sill•David T. W. Jones•Stefan M. Pfister•Felix Sahm等 8 人
Nature Communications
2025
•2025/2/20
•Vol.16 No.1 p.1-11
We have recently developed a machine learning classifier that enables fast, accurate, and affordable classification of brain tumors based on genome-wide DNA methylation profiles that is widely employed in the clinic. Neuro-oncology research would benefit greatly from understanding the underlying art...
Cancer genomicsCNS cancerDiagnostic markersMachine learningOncogenes
10.1038/S41467-025-57078-0
ISSN:2041-1723
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Yura Grabovska•Alan Mackay•Patricia O’Hare•Stephen Crosier•Martina Finetti等 23 人
Nature Communications
2020
•2020/8/28
•Vol.11 No.1 p.1-15
Immune-therapy is an attractive alternative therapeutic approach for targeting central nervous system (CNS) tumors and the constituency of the Tumor Immune Microenvironment (TIME) likely to predict patient response. Here, we describe the TIME of >6000 primarily pediatric CNS tumors using a deconvolu...
Cancer genomicsPaediatric cancer
10.1038/S41467-020-18070-Y
ISSN:2041-1723